Response of patients with refractory myasthenia gravis to rituximab: a retrospective study-Reference-Cited by-同舟云学术

Response of patients with refractory myasthenia gravis to rituximab: a retrospective study

Published:2011-07-04 Issue:5 Volume:4 Page:259-266
ISSN:1756-2856
Container-title:Therapeutic Advances in Neurological Disorders
language:en
Short-container-title:Ther Adv Neurol Disord

Author:

Nowak Richard J.¹,DiCapua Daniel B.²,Zebardast Nazlee²,Goldstein Jonathan M.¹

Affiliation:

1. Yale University School of Medicine, Department of Neurology, Division of Neuromuscular Disorders, 15 York Street, LCI #902, New Haven, CT 06510, USA

2. Department of Neurology, Yale University School of Medicine, New Haven, CT, USA

Publisher

SAGE Publications

Subject

Clinical Neurology,Neurology,Pharmacology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1756285611411503

Reference26 articles.

1. Complete remission induced by rituximab in refractory, seronegative, muscle-specific, kinase-positive myasthenia gravis

2. An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab

3. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

4. Myasthenia gravis: past, present, and future

5. Invited Article: Inhibition of B cell functions: Implications for neurology

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the depths of IgG4: insights into autoimmunity and novel treatments;Frontiers in Immunology;2024-04-18

2. Unlocking the Complexity of Neuromuscular Diseases: Insights from Human Pluripotent Stem Cell-Derived Neuromuscular Junctions;International Journal of Molecular Sciences;2023-10-18

3. Rituximab treatment in myasthenia gravis;Frontiers in Neurology;2023-10-02

4. Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease;Frontiers in Immunology;2023-07-26

5. Rituximab for myasthenia gravis;Cochrane Database of Systematic Reviews;2023-04-05